Showing 7621-7630 of 9101 results for "".
- New Partnership for Revision Skincare, RVL Pharmaceuticalshttps://practicaldermatology.com/news/new-partnership-for-revision-skincare-rvl-pharmaceuticals/2461320/With a goal to collaborate on a variety of marketing efforts within the medical aesthetics industry, Revision Skincare® and RVL Pharmaceuticals, Inc. the owner of UPNEEQ®, are partnering to address what they see as significant unmet consumer needs. Revisions
- Tecovirimat Safe and Effective for Treating Skin Lesions of Monkeypoxhttps://practicaldermatology.com/news/tecovirimat-safe-and-effective-for-treating-skin-lesions-of-monkeypox/2461318/The antiviral tecovirimat appears to be safe and effective for the treatment of monkeypox symptoms and skin lesions, according to a research letter published in JAMA. The study is one of the ea
- Ivermectin to Treat Scabies on Mass Scale in Solomon Islandshttps://practicaldermatology.com/news/ivermectin-to-treat-scabies-on-mass-scale-in-solomon-islands/2461317/The anti-parasitic drug ivermectin will be rolled out on mass scale in the Solomon Islands to prevent scabies.
- Cutera Recognized by 50/50 Women on Boards for Gender-Balanced Board of Directorshttps://practicaldermatology.com/news/cutera-recognized-by-5050-women-on-boards-for-gender-balanced-board-of-directors/2461315/The 50/50 Women on Boards recognized Cutera for having a gender-balanced board. With four women directors, holding 50 percent of its corporate board seats, Cutera, Inc. is one of only 8 percent (just 241) of Russell 3000 companies with a gender-balanced board. &ldq
- La Roche-Posay Becomes the First-Ever Official Sunscreen of the US Openhttps://practicaldermatology.com/news/la-roche-posay-becomes-the-first-ever-official-sunscreen-of-the-us-open/2461314/La Roche-Posay is the official sunscreen partner of the US Open. Beginning with this year's US Open, La Roche-Posay will have a sun safety education booth in the South Plaza of the USTA Billie Jean King National Tennis Center, with two additional product sampling kiosks on the
- First Patient Dosed in Phase 1b/2 Trial of Dermaliq Therapeutics's DLQ02 for PsOhttps://practicaldermatology.com/news/first-patient-dosed-in-phase-1b2-trial-of-dermaliq-therapeuticss-dlq02-for-pso/2461310/The first patient has been dosed in a Phase 1b/2a trial with DLQ02, a topical calcineurin inhibitor, Dermaliq Therapeutics, Inc. reports. The trial is designed to evaluate the safety, systemic absorption, pharmacodynamics, and clinical efficacy of DLQ02 in patients with plaqu
- Pulsed-Dye Laser Reduces the Effects of Hypertrophic Scars Post-thyroidectomyhttps://practicaldermatology.com/news/pulsed-dye-laser-reduces-the-effects-of-hypertrophic-scars-post-thyroidectomy/2461308/Treatment with a 595 nm pulsed dye laser (PDL) can prevent and improve hypertrophic scars in patients with post-thyroidectomy in a cost-effective fashion, a new study shows. For the study, 19 patients with hypertrophic scars after thyroidectomy underwent
- Survey: Many Skip Yearly Derm Visitshttps://practicaldermatology.com/news/survey-many-skip-yearly-derm-visits/2461306/Many folks are avoiding the dermatologist and other specialists, according to a nationwide survey of more than 1,050 people by Myvision.org Fully 48 percent of survey respondents don’t remember the last time they went to the dermatologist, and only 10 percent
- Joe Jonas Named New Xeomin Brand Partnerhttps://practicaldermatology.com/news/joe-jonas-named-new-xeomin-brand-partner/2461305/Joe Jonas is the latest Xeomin (incobotulinumtoxinA) brand partner, Merz Aesthetics announced. The U.S. partnership with Jonas kicks off a new ‘Beauty on Your Terms’ campaign for Xeomin and represents the first time the singer, songwr
- Epidural Nerve Block with Lidocaine Leads to Clearance of Psoriatic Skin Lesionshttps://practicaldermatology.com/news/epidural-nerve-block-with-lidocaine-leads-to-clearance-of-psoriatic-skin-lesions/2461297/Use of an epidural nerve block with lidocaine leads to clearance of psoriatic skin lesions, according to a novel proof-of-concept study in the Journal of Investigative Dermatology. “Case studies have shown that psoriasis patients have experienced significant symptom